Bank of Montreal
WHWK

Bank of Montreal’s Whitehawk Therapeutics WHWK Stock Holding History

Bank of Montreal’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-22,572
Closed -$188K – 4301
2023
Q2 		$188K Buy
+22,572
New +$175K ﹤0.01% 3243

Other funds holding WHWK

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of Montreal's WHWK Position: Q3 2023 in Review

Bank of Montreal sold out of Whitehawk Therapeutics (WHWK) in Q3 2023, closing a stake of 22,572 shares — an estimated $188K sold.

Bank of Montreal first reported a position in WHWK in Q2 2023 and held it in 1 quarter. The position peaked at $188K in Q2 2023. 73 funds tracked by Wall St. Rank hold WHWK as of Q3 2023.

  • Bank of Montreal reported no remaining Whitehawk Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Bank of Montreal sold 22,572 Whitehawk Therapeutics shares in Q3 2023, an estimated $188K.
  • Bank of Montreal first reported a position in Whitehawk Therapeutics in Q2 2023 and held it in 1 quarter.
  • Bank of Montreal's Whitehawk Therapeutics position peaked at $188K in Q2 2023.
  • 73 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q3 2023.

Based on Bank of Montreal's 13F filing for Q3 2023, filed 1 Nov 2023.